价格

human glucagon

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ACYLATED GLUCAGON ANALOGUES
- EP 3057984 B1
  申请人: ZEALAND PHARMA AS优先权: 2013
  CN
  EP
  US
  WO
  17 件公开
- CN 104961822 A
  申请人: ZEALAND PHARMA AS优先权: 2010
  CN
  US
  4 件公开
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
EP 3608338 B1申请人: REGENERON PHARMA优先权: 2010
EP
US
WO
17 件公开
Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
US 10610572 B2申请人: ADOCIA优先权: 2017
CN
EP
US
WO
8 件公开
DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF
US 2023190879 A1申请人: BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD优先权: 2020
CN
EP
US
WO
7 件公开
GLP-1/GIP DUAL AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4556487 A1申请人: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO LTD优先权: 2022
CN
EP
US
WO
7 件公开
MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF
US 2022168396 A1申请人: JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD优先权: 2019
CN
EP
US
WO
5 件公开
LONG ACTING GLP-1/GIP DUAL AGONISTS
EP 4146248 A1申请人: SUN PHARMACEUTICAL IND LTD优先权: 2020
CN
EP
US
WO
5 件公开
GLP-1/GIP DUAL AGONISTS
EP 4204440 A1申请人: SUN PHARMACEUTICAL IND LTD优先权: 2020
CN
EP
US
WO
5 件公开
GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF
EP 3733694 A1申请人: INTARCIA THERAPEUTICS INC优先权: 2016
CN
EP
US
5 件公开
Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
US 8551946 B2申请人: DIMARCHI RICHARD D优先权: 2011
CN
US
5 件公开

药物

human glucagon

专利

ACYLATED GLUCAGON ANALOGUES